Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Voskoboynik

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Asia-Pacific Journal of Clinical Oncology|June 17, 2025
A New Dawn-Using Teletrials for Early Phase Drug Development: A Practical GuidelineG Gaughran, J Zalcberg, M Voskoboynik, et al.
Internal Medicine Journal|June 5, 2014
High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patientsJ Lewin, M Dickinson, M Voskoboynik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2012
An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancerM Voskoboynik, S Bae, S Ananda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2021
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer<sup>☆</sup>J Niu, C Maurice-Dror, D H Lee, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Asia-Pacific Journal of Clinical Oncology|June 17, 2025
A New Dawn-Using Teletrials for Early Phase Drug Development: A Practical GuidelineG Gaughran, J Zalcberg, M Voskoboynik, et al.
Internal Medicine Journal|June 5, 2014
High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patientsJ Lewin, M Dickinson, M Voskoboynik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2012
An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancerM Voskoboynik, S Bae, S Ananda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2021
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer<sup>☆</sup>J Niu, C Maurice-Dror, D H Lee, et al.
Pageof 1